Inhibitory Effect of a Phosphatidyl Ethanolamine Derivative on LPS-Induced Sepsis
![]() |
Lee, Chunghyun
(Department of Biology, School of Bioscience and Biotechnology, Chungnam National University)
An, Hyun-Jung (Department of Biology, School of Bioscience and Biotechnology, Chungnam National University) Kim, Jung-In (Department of Chemistry, Korea Advanced Institute of Science and Technology) Lee, Hayyoung (Department of Biology, School of Bioscience and Biotechnology, Chungnam National University) Paik, Sang-Gi (Department of Biology, School of Bioscience and Biotechnology, Chungnam National University) |
1 | Angus, D.C., Linde-Zwirble, W.T., Lidicker, J., Clermont, G., Carcillo, J., and Pinsky, M.R. (2001). Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29, 1303-1310 DOI ScienceOn |
2 | Gregory, C.D., and Devitt, A. (1999). CD14 and apoptosis. Apoptosis 4, 11-20 DOI ScienceOn |
3 | Schimke, J., Mathison, J., Morgiewicz, J., and Ulevitch, R.J. (1998). Anti-CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin. Proc. Natl. Acad. Sci. USA 95, 13875-13880 DOI ScienceOn |
4 | Kim, J.I., Lee, C.J., Jin, M.S., Lee, C.H., Paik, S.G., Lee, H., and Lee, J.O. (2005). Crystal structure of CD14 and its implications for lipopolysaccharide signaling. J. Biol. Chem. 280, 11347-11351 DOI ScienceOn |
5 | Rossignol, D.P., and Lynn, M. (2005). TLR4 antagonists for endotoxemia and beyond. Curr. Opin. Investig. Drugs 6, 496-502 |
6 | Triantafilou, M., and Triantafilou, K. (2002). Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol. 23, 301-304 DOI ScienceOn |
7 | Haziot, A., Ferrero, E., Kontgen, F., Hijiya, N., Yamamoto, S., Silver, J., Stewart, C.L., and Goyert, S.M. (1996). Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 4, 407-414 DOI ScienceOn |
8 | Angus, D.C., and Wax, R.S. (2001). Epidemiology of sepsis: an update. Crit. Care Med. 29, S109-116 DOI |
9 | Spyvee, M.R., Zhang, H., Hawkins, L.D., and Chow, J.C. (2005). Toll-like receptor 2 antagonists. Part 1: preliminary SAR investigation of novel synthetic phospholipids. Bioorg. Med. Chem. Lett. 15, 5494-5498 DOI ScienceOn |
10 | Tasaka, S., Ishizaka, A., Yamada, W., Shimizu, M., Koh, H., Hasegawa, N., Adachi, Y., and Yamaguchi, K. (2003). Effect of CD14 blockade on endotoxin-induced acute lung injury in mice. Am. J. Respir. Cell Mol. Biol. 29, 252-258 DOI ScienceOn |
11 | Raetz, C.R., and Whitfield, C. (2002). Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71, 635-700 DOI ScienceOn |
12 | Mullarkey, M., Rose, J.R., Bristol, J., Kawata, T., Kimura, A., Kobayashi, S., Przetak, M., Chow, J., Gusovsky, F., Christ, W.J., et al. (2003). Inhibition of endotoxin response by e5564, a novel Tolllike receptor 4-directed endotoxin antagonist. J. Pharmacol. Exp. Ther. 304, 1093-1102 DOI ScienceOn |
13 | Bochkov, V.N., Kadl, A., Huber, J., Gruber, F., Binder, B.R., and Leitinger, N. (2002). Protective role of phospholipid oxidation products in endotoxin-induced tissue damage. Nature 419, 77-81 DOI ScienceOn |
14 | Wright, S.D., Ramos, R.A., Tobias, P.S., Ulevitch, R.J., and Mathison, J.C. (1990). CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249, 1431-1433 DOI |
15 | Tobias, P.S., Soldau, K., Iovine, N.M., Elsbach, P., and Weiss, J. (1997). Lipopolysaccharide (LPS)-binding proteins BPI and LBP form different types of complexes with LPS. J. Biol. Chem. 272, 18682-18685 DOI ScienceOn |
16 | Ulevitch, R.J., and Tobias, P.S. (1995). Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13, 437-457 DOI ScienceOn |
17 | Wang, P.Y., Kitchens, R.L., and Munford, R.S. (1998). Phosphatidylinositides bind to plasma membrane CD14 and can prevent monocyte activation by bacterial lipopolysaccharide. J. Biol. Chem. 273, 24309-24313 DOI ScienceOn |
18 | Bas, S., Gauthier, B.R., Spenato, U., Stingelin, S., and Gabay, C. (2004). CD14 is an acute-phase protein. J. Immunol. 172, 4470-4479 DOI |
19 | Dziarski, R., Tapping, R.I., and Tobias, P.S. (1998). Binding of bacterial peptidoglycan to CD14. J. Biol. Chem. 273, 8680-8690 DOI ScienceOn |
![]() |